Cetirizine hydrochloride and Remodulin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cetirizine hydrochloride (cetirizine hydrochloride) and Remodulin (treprostinil sodium). Common drug interactions include infusion site erythema among females and dermatitis contact among males.
The phase IV clinical study analyzes what interactions people have when they take Cetirizine hydrochloride and Remodulin. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Cetirizine hydrochloride?
Cetirizine hydrochloride has active ingredients of cetirizine hydrochloride. It is often used in allergies. eHealthMe is studying from 34,910 Cetirizine hydrochloride users. Check the latest studies of Cetirizine hydrochloride.
What is Remodulin?
Remodulin has active ingredients of treprostinil sodium. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,843 Remodulin users. Check the latest studies of Remodulin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
13 people who take Cetirizine hydrochloride and Remodulin together, and have interactions are studied.

What are the common drug interactions of Cetirizine Hydrochloride and Remodulin, by gender? *:
female:
- Infusion site erythema (reddening of the skin at infusion site)
- Infusion site pain
- Cardiac failure congestive
- Ascites (accumulation of fluid in the abdominal cavity)
- Drug hypersensitivity
- Infusion site haemorrhage (bleeding from infusion site)
- Infusion site induration
- Infusion site reaction
- Infusion site swelling
- Infusion site warmth
male:
- Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
- Abdominal discomfort
- Fall
- Fluid retention (an abnormal accumulation of fluid in the blood)
- Head discomfort
- Hypokalaemia (low potassium)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Hypotension (abnormally low blood pressure)
- Infusion site infection
- Joint injury
What are the common drug interactions of Cetirizine Hydrochloride and Remodulin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
- Bone marrow failure
- Diarrhoea
10-19:
n/a
20-29:
n/a
30-39:
- Skin exfoliation (removal of the oldest dead skin cells)
40-49:
- Burning sensation
- Infusion site rash
- Pain
50-59:
n/a
60+:
- Breast cancer
- Breast pain
- Haemorrhage (bleeding)
- Hypertension (high blood pressure)
- Multi-organ failure (multisystem organ failure)
- Oral candidiasis (fungal infection of mouth)
- Pericardial effusion (fluid around the heart)
- Pleural effusion (water on the lungs)
- Pneumonia
- Pulmonary arterial pressure increased
What are the existing conditions these people have? *
- Pain: 2 people, 15.38%
- Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 7.69%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 7.69%
- Rashes (redness): 1 person, 7.69%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.69%
- Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 1 person, 7.69%
- Fever: 1 person, 7.69%
- Diarrhea: 1 person, 7.69%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 7.69%
- Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Cetirizine hydrochloride and Remodulin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cetirizine hydrochloride (34,910 reports)
- Remodulin (55,843 reports)
Browse all drug interactions of Cetirizine hydrochloride and Remodulin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cetirizine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Remodulin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cetirizine hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Remodulin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cetirizine hydrochloride and treprostinil sodium (the active ingredients of Cetirizine hydrochloride and Remodulin, respectively), and Cetirizine hydrochloride and Remodulin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Prograf cause Abdominal Pain? - 5 seconds ago
- Drug interactions of Mirtazapine and Hydroxyzine - 6 seconds ago
- Could Sodium Polystyrene Sulfonate cause Fatigue Aggravated? - 8 seconds ago
- Acute Myeloid Leukaemia and The Flu - 10 seconds ago
- Could Megestrol Acetate cause Pain Of Skin? - 10 seconds ago
- Drug interactions of Sudafed 12 Hour and Allegra Allergy - 11 seconds ago
- Acromegaly and Toothaches - 14 seconds ago
- Could Acetaminophen cause Faeces Discolored? - 14 seconds ago
- Acne and Attention Deficit Hyperactivity Disorder - 18 seconds ago
- Acne and Attention Deficit/Hyperactivity Disorder - 18 seconds ago